Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | F10 | P00742 | 2/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.45 |
| ▸ | LOX | P28300 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29607042 | 1.00 | MAPT (0.65) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL17764739 | 0.92 | MAPT (0.58) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL8507695 | 0.91 | MAPT (0.56) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL8941516 | 0.90 | MAPT (0.59) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL3457474 | 0.89 | MAPT (0.58) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL17772777 | 0.89 | MAPT (0.61) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL28076151 | 0.89 | MAPT (0.58) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL3458428 | 0.89 | MAPT (0.58) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL7110619 | 0.87 | MAPT (0.74) | MAPTL3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL8507324 | 0.86 | MAPT (0.56) | MAPTL3MBTL1ALDH1A1POLBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220140258-A1 | IRIDIUM COMPLEX, NITROGEN-CONTAINING TRIDENTATE CARBENE CHELATE, AND ORGANIC LIGHT-EMITTING DIODE | NATIONAL TSING HUA UNIVERSITY (TW) | 2022-05-05 | — | — | US | disclosed |
| US-5691277-A | REACTING A 2,6-DIHALOGENOPYRIDINE WITH A META SUBSTITUTED PHENOL | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1997-11-25 | — | — | US | disclosed |
| EP-0692474-B1 | 2- (unsubstituted or substituted) (benzyloxy or phenoxy)-4-substituted-6-(meta-substituted phenoxy) pyridine, process for producing the same, and herbicidal composition | KUREHA CHEMICAL IND CO LTD (JP) | 1997-10-29 | — | — | EP | disclosed |
| EP-0692474-A1 | 2- (unsubstituted or substituted) (benzyloxy or phenoxy)-4-substituted-6-(meta-substituted phenoxy) pyridine, process for producing the same, and herbicidal composition | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1996-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220140258-A1 | IRIDIUM COMPLEX, NITROGEN-CONTAINING TRIDENTATE CARBENE CHELATE, AND ORGANIC LIGHT-EMITTING DIODE | NR2E3, CHRM1, CBR3 | MAPT 3218/4885L3MBTL1 317/4885ALDH1A1 3552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.